Wuhan Keqian Biology Co., Ltd (688526.SH) plans to sign a cooperation research and development agreement with Huazhong Agricultural University.

Wuhan Keqian Biology Co., Ltd (688526.SH) announced that, in order to enhance the company's market competitiveness and accelerate its development in the biological products industry, to better improve the company's brand influence and core competitiveness, according to the company's articles of association, cooperation research and development management system, after competitive negotiations with Huazhong Agricultural University, the company has obtained the cooperation research and development of the "Quad Vaccine (Feline Panleukopenia Virus, Feline Calicivirus, Feline Herpesvirus, Feline Chlamydia) Inactivated Vaccine and Feline Chlamydia Inactivated Vaccine" project. It is proposed to sign a joint cooperation research and development agreement with Huazhong Agricultural University for the above project, and the company will pay 1 million RMB to Huazhong Agricultural University for the research and development project. Through cooperation in research and development, the company can increase its product reserves and enhance its market competitiveness. This cooperation research and development is a new project research and development, and there is uncertainty regarding the success of product development, the time of product launch, and the market promotion after product launch. The company is unable to predict its current and future performance.